Nordic Issuing

Ongoing case

NeoDynamics AB (publ)

Back to all cases

NeoDynamics AB (publ)

21 Oct - 19 Nov 2020Directed issue

NeoDynamics AB (publ) is a Swedish medtech company focused on develop diagnosis and treatment of cancer. The company has an innovative biopsy system, NeoNavia, which is built on a patented pulsing technique based on research from Karolinska Institutet.

The system is designed to provide doctors and patients a precise and credible biopsy with a great exchange for a correct diagnosis and individualized treatment. NeoNavia is being evaluated by leading clinics in Great Britain, Germany and Sweden. A commercial launch is planned to take place during 2020.

Read more on the company's website

The offer in summary

Share capital increase: Approximately 90 MSEK

Number of shares: 24 243 641

Subscription price: 3.71 SEK

Sole Manager och Bookrunner: Stockholm Corporate Finance AB

Documents

  Press release

Disclaimer

Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.